{"ModuleTitle": "Company Description", "CompanyName": "Cleveland BioLabs, Inc.", "Symbol": "CBLI", "Address": "73 HIGH STREET, BUFFALO, New York, 14203, United States of America", "Phone": "(716) 849-6810", "Industry": "Biotechnology: Commercial Physical & Biological Resarch", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "When used in this Annual Report on Form 10-K, unless otherwise stated or the\r\ncontext otherwise requires, the terms \"Cleveland BioLabs,\" the \"Company,\"\r\n\"CBLI,\" \"we,\" \"us,\" and \"our\" refer to Cleveland BioLabs, Inc. and its\r\nconsolidated subsidiaries, BioLab 612, LLC and Panacela Labs, Inc.\r\n\r\n \r\n\r\nGENERAL OVERVIEW\r\n\r\n \r\n\r\nCleveland BioLabs is an innovative biopharmaceutical company developing novel\r\napproaches to activate the immune system and address serious medical needs. Our\r\nproprietary platform of Toll-like immune receptor activators has applications in\r\nmitigation of radiation injury and immuno-oncology. We combine our proven\r\nscientific expertise and our depth of knowledge about our products' mechanisms\r\nof action into a passion for developing drugs to save lives.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f04%2f15%2f0001437749-20-007716.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andrei V. Gudkov", "title": "Chief Scientific Officer"}, {"name": "Christopher Zosh", "title": "Chief Executive Officer, CAO & VP-Finance"}, {"name": "Langdon L. Miller", "title": "President & Chief Medical Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["Panacela Labs"]}